Microviable Therapeutics SL received funding under Eurostars-3 Program co-financed by CDTI (Spanish National Agency) and the Research and Innovation Funding Program Horizon Europe. The project “Microbiome-based medicinal products to increase the efficacy of immunotherapy” MICROBOOST, [...]
Microviable has received the 2025 Microbiome Research Reports High-Impact Paper Award, a recognition to an outstanding scientific review manuscript published in 2025 in the journal Microbiome Research Reports. Our CTO, David Ríos Covián, PhD, lead [...]
During March 18-19th, Microviable will be attending the Microbiome Times Partnering Forum taking place in Copenhagen, joining other cutting-edge biotech companies, VCs, and pharma companies during the two days of the event. Microviable will have [...]
Microviable obtained two projects funded under CanSERV European call focused on "Reaching and Understanding of Cancer". We are proud to announce that our research proposal “Exploring the relationships between anti-PD1 responders and gut microbiota: intervention [...]
At Microviable we are proud and thankful to SEKUENS, Agencia de Ciencia, Competitividad Empresarial e Innovación del Principado de Asturias, for the four projects approved in 2025 with competitive funding! We will keep pushing for [...]
Pilar Manrique, PhD, senior scientist at Microviable Therapeutics will be present at the 10th Microbiome Microbiome Movement Summit taking place in London, in January 28-29th 2026! Pilar Manrique will be presenting on Thursday 29th at [...]
Microviable Therapeutics will be attending LSX Inv€$tival Showcase Claudio Hidalgo, PhD, cofounder and CEO and Noelia Martínez, PhD, cofounder and R&D Director at Microviable Therapeutics, will be attending LSX Inv€$tival Showcase in London on November [...]
World Microbiome Day is here another year!! The World Microbiome Day was created for raising awareness about the fascinating world of microbiomes and their impact on our health and the environment. The human microbiome is [...]
Microviable Therapeutics will be attending Bio International Convention 2025 in Boston Claudio Hidalgo, PhD., cofounder and CEO, will be attending the BIO International Convention 2025 event, taking place in Boston during June 16th-19th. This four-day [...]
Microviable Therapeutics joins the European Microbiome Innovation for Health (EMIH) EMIH is an independent European coalition, a public and private initiative, and a non-profit organization aiming to ensure that microbiome-based medical innovations become a public [...]